{"id":"https://openalex.org/W2028113587","doi":"https://doi.org/10.1002/pds.2092","title":"The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case\u2013control study","display_name":"The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case\u2013control study","publication_year":2010,"publication_date":"2010-12-28","ids":{"openalex":"https://openalex.org/W2028113587","doi":"https://doi.org/10.1002/pds.2092","mag":"2028113587","pmid":"https://pubmed.ncbi.nlm.nih.gov/21351310"},"language":"en","primary_location":{"id":"doi:10.1002/pds.2092","doi":"https://doi.org/10.1002/pds.2092","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.2092","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065076079","display_name":"Florence P. A. M. van Hunsel","orcid":"https://orcid.org/0000-0001-8965-3224","observed_orcids":["https://orcid.org/0000-0001-8965-3224"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]},{"id":"https://openalex.org/I4210139651","display_name":"Netherlands Pharmacovigilance Centre Lareb","ror":"https://ror.org/04fp8ns78","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210139651"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Florence van Hunsel","raw_affiliation_strings":["Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands. f.vanhunsel@lareb.nl","Department of Pharmacy: Pharmacotherapy and Pharmaceutical Care, University of Groningen, The Netherlands","Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands. f.vanhunsel@lareb.nl","institution_ids":["https://openalex.org/I4210139651"]},{"raw_affiliation_string":"Department of Pharmacy: Pharmacotherapy and Pharmaceutical Care, University of Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands","institution_ids":["https://openalex.org/I4210139651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071481371","display_name":"Attje Talsma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Attje Talsma","raw_affiliation_strings":["Department of Pharmacy: Pharmacotherapy and Pharmaceutical Care, University of Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy: Pharmacotherapy and Pharmaceutical Care, University of Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073876435","display_name":"Eug\u00e8ne van Puijenbroek","orcid":"https://orcid.org/0000-0002-2236-1398","observed_orcids":["https://orcid.org/0000-0002-2236-1398"]},"institutions":[{"id":"https://openalex.org/I4210139651","display_name":"Netherlands Pharmacovigilance Centre Lareb","ror":"https://ror.org/04fp8ns78","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210139651"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Eug\u00e8ne van Puijenbroek","raw_affiliation_strings":["Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands","institution_ids":["https://openalex.org/I4210139651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040001367","display_name":"Lolkje de Jong\u2010van den Berg","orcid":"https://orcid.org/0000-0002-9589-3432","observed_orcids":["https://orcid.org/0000-0002-9589-3432"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Lolkje de Jong\u2010van den Berg","raw_affiliation_strings":["Department of Pharmacy: Pharmacoepidemiology & Pharmacoeconomics, University of Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy: Pharmacoepidemiology & Pharmacoeconomics, University of Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020000643","display_name":"Kees van Grootheest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]},{"id":"https://openalex.org/I4210139651","display_name":"Netherlands Pharmacovigilance Centre Lareb","ror":"https://ror.org/04fp8ns78","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210139651"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Kees van Grootheest","raw_affiliation_strings":["Department of Pharmacy: Pharmacotherapy and Pharmaceutical Care, University of Groningen, The Netherlands","Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy: Pharmacotherapy and Pharmaceutical Care, University of Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands","institution_ids":["https://openalex.org/I4210139651"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5065076079"],"corresponding_institution_ids":["https://openalex.org/I169381384","https://openalex.org/I4210139651"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":3.7719,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.9198628,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"20","issue":"3","first_page":"286","last_page":"291"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10902","display_name":"Complementary and Alternative Medicine Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8870000243186951},{"id":"https://openalex.org/keywords/patient-reports","display_name":"patient reports","score":0.9430000185966492},{"id":"https://openalex.org/keywords/signal-detection","display_name":"signal detection","score":0.765999972820282},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.921999990940094},{"id":"https://openalex.org/keywords/lareb","display_name":"Lareb","score":0.6710000038146973},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9490984678268433},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.7402399778366089},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.35459020733833313},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3201259970664978},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.16783007979393005},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009313","descriptor_name":"National Health Programs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D009426","descriptor_name":"Netherlands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010358","descriptor_name":"Patient Participation","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1002/pds.2092","doi":"https://doi.org/10.1002/pds.2092","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.2092","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},{"id":"pmid:21351310","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21351310","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and drug safety","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/330fdf75-4e2b-41c5-a51b-296caaa6e77a","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/330fdf75-4e2b-41c5-a51b-296caaa6e77a","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"van Hunsel, F, Talsma, A, van Puijenbroek, E, de Jong-van den Berg, L & van Grootheest, K 2011, 'The proportion of patient reports of suspected ADRs to signal detection in the Netherlands : case-control study', Pharmacoepidemiology and Drug Safety, vol. 20, no. 3, pp. 286-291. https://doi.org/10.1002/pds.2092","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/330fdf75-4e2b-41c5-a51b-296caaa6e77a","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/330fdf75-4e2b-41c5-a51b-296caaa6e77a","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacoepidemiology and Drug Safety, 20(3), 286 - 291. Wiley","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.979200005531311,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W196138976","https://openalex.org/W583572480","https://openalex.org/W1562265147","https://openalex.org/W1977051409","https://openalex.org/W1994043460","https://openalex.org/W2018164189","https://openalex.org/W2037155736","https://openalex.org/W2041096144","https://openalex.org/W2110931670","https://openalex.org/W2116875770","https://openalex.org/W2140742150","https://openalex.org/W2151072354","https://openalex.org/W2806773374","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2490263158","https://openalex.org/W2614636634","https://openalex.org/W1968111376","https://openalex.org/W2151072354","https://openalex.org/W2793614962","https://openalex.org/W1994043460","https://openalex.org/W2754333639","https://openalex.org/W2134806789","https://openalex.org/W1584926918","https://openalex.org/W1562265147"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"determine":[2],"the":[3,19,25,55,79,88,155,164,186,202,208,222,233,241,249],"contribution":[4,220],"of":[5,18,33,41,57,95,116,135,192,204,212,224,243],"patients'":[6],"adverse":[7,42,213,244],"drug":[8,43,214,245],"reaction":[9],"(ADR)":[10],"reports":[11,36,59,86,97,107,112,121,138,150,156,166,194,206,211,237],"to":[12,24,38,52,77,100,110,126,169,196,201,221,228,240,248],"signals":[13,20,40,198,225,242],"detection,":[14],"through":[15],"a":[16,101,130,142,170,218],"study":[17,53],"sent":[21,247],"by":[22,141],"Lareb":[23],"Dutch":[26],"Medicines":[27,250],"Evaluation":[28,251],"Board.":[29,252],"METHODS:":[30],"The":[31,93,144,190],"percentage":[32],"patient's":[34],"ADR":[35],"contributing":[37,168,195],"generate":[39,197],"reactions":[44,215,246],"was":[45,50,75,175,199],"determined.":[46],"A":[47,71],"case-control":[48,145],"design":[49],"used":[51,76,157],"if":[54],"proportion":[56,191,203],"patient":[58,85,96,120,149,193,205,236],"in":[60,87,108,113,154,158,163,207,226],"associations":[61,125],"that":[62,148],"had":[63],"been":[64],"selected":[65,128],"as":[66,129,162],"'signals'":[67],"differed":[68],"from":[69,105],"non-signals.":[70],"logistic":[72],"regression":[73],"analysis":[74,146],"calculate":[78],"Odds":[80,172],"Ratio":[81,173],"with":[82],"95%CI":[83],"for":[84,185],"cases":[89],"and":[90,179],"controls.":[91],"RESULTS:":[92],"number":[94],"which":[98],"contributed":[99],"signal":[102,159],"has":[103],"increased":[104],"0":[106],"2003":[109],"31":[111],"2008":[114],"(9%":[115],"total).":[117],"Since":[118],"2005":[119],"have":[122,238],"triggered":[123],"particular":[124],"be":[127],"signal.":[131,171],"In":[132,232],"2007,":[133],"28%":[134],"all":[136],"trigger":[137],"were":[139,151],"reported":[140],"patient.":[143],"showed":[147],"equally":[152],"present":[153],"formation":[160],"(cases)":[161],"controls,":[165],"not":[167],"(OR)":[174],"1.10":[176],"(95%CI":[177,183],"0.81-1.49)":[178],"OR":[180],"=":[181],"0.96":[182],"0.50-1.87)":[184],"'trigger":[187],"reports'.":[188],"CONCLUSIONS:":[189],"equal":[200],"database.":[209],"Patient's":[210],"can":[216],"provide":[217],"valuable":[219],"detection":[223],"addition":[227],"healthcare":[229],"professionals'":[230],"reports.":[231],"Netherlands,":[234],"direct":[235],"added":[239]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}